Dr. Bresnik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Lakeside Dr
Foster City, CA 94404Phone+1 650-522-5934
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 1982 - 1983
UCLA-VA Greater Los AngelesInternship, Internal Medicine, 1978 - 1979
University of Illinois College of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1979 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects Start of enrollment: 2012 Oct 01
- Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA) Start of enrollment: 2016 Jan 26
- Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy Start of enrollment: 2016 Aug 08
Publications & Presentations
PubMed
- 470 citationsLiposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)Oliver A. Cornely, Johan Maertens, Mark Bresnik, Ramin Ebrahimi, Andrew J. Ullmann
Clinical Infectious Diseases. 2007-05-15 - 57 citationsRandomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.Oliver A. Cornely, Thibaut Leguay, Johan Maertens, Maria J G T Vehreschild, Achilles Anagnostopoulos
The Journal of Antimicrobial Chemotherapy. 2017-08-01 - 102 citationsInhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial☆Baroukh M. Assael, Tacjana Pressler, Diana Bilton, Michael Fayon, Rainald Fischer
Journal of Cystic Fibrosis. 2013-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
